Horizon Discovery Extends Coverage of OncoSpan Reference Standards to FFPE and Liquid Biopsy
OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively
Horizon Discovery Group
Articles by Horizon Discovery Group
Horizon Discovery Expands Cell-Based CRISPR Screening Services
New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system
Horizon Discovery Signs Collaboration and License Agreement with Mammoth Biosciences
Company aims to develop the next generation of engineered CHO cell lines to improve production of biotherapeutics
Horizon Discovery to Provide Access to Novel Base Editing Technology
Next-generation gene editing system has applications in development of cell and gene therapies
Horizon Discovery Partners with the Human Protein Atlas
Agreement will expand open access resource, supporting genetic research globally
Horizon Discovery Divests Animal Models Business to Envigo
Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business
Horizon Discovery Introduces Myeloid DNA Reference Standard to Support Genetic Testing of Leukemia
First-to-market cell line-derived reference standard for myeloid blood cancers
Horizon Discovery Announces Collaboration with Major Pharmaceutical Company on Single Cell RNAseq-Linked CRISPR Screening
Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation
Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening
First-to-market Edit-R CRISPRa arrayed crRNA libraries enable native gene overexpression for high-throughput gain-of-function screening